Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Trastuzumab increases the clinical benefit of first-line chemotherapy in metastatic breast cancer that overexpresses HER2.
Publications
2 shownTalazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation
Among patients with advanced breast cancer and a germline BRCA1/2 mutation, single-agent talazoparib provided a significant benefit over standard chemotherapy with respect to pr...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 13,295
- Institution
- Krankenhaus vom Roten Kreuz
External Links
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.